Retroperitoneal lymph node dissection: Reassessment of modified templates

BJU International

Volumn 104, Issue 9 B, 2009, Pages 1369-1375

  Large, Michael C ^a   Sheinfeld, Joel ^b   Eggener, Scott E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Modified template; Nerve sparing; Retroperitoneal lymph node dissection; Testicular cancer

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER STAGING; CHYLOUS ASCITES; CLINICAL TRIAL; HUMAN; INTESTINE INJURY; LYMPH NODE DISSECTION; MINIMAL RESIDUAL DISEASE; NEPHRECTOMY; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; RETROGRADE EJACULATION; RETROPERITONEAL CANCER; REVIEW; SURGICAL TECHNIQUE; SYMPATHETIC NERVE;

ANTINEOPLASTIC AGENTS; EJACULATION; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL ILLUSTRATION; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL NEOPLASMS; TESTICULAR NEOPLASMS; TRAUMA, NERVOUS SYSTEM;

EID: 70350433406     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08861.x     Document Type: Review

References (27)

1. Stephenson AJ, Sheinfeld J. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 2004 22 : 225 233
2. Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 2009 181 : 627 632
3. Donohue JP. Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT). Urol Oncol 2003 21 : 129 132
4. Hinman F. The operative treatment of tumors of the testicle. JAMA 1914 58 : 2009 2014
5. Patton JF, Hewitt CB, Mallis N. Diagnosis and treatment of tumors of the testis. J Am Med Assoc 1959 171 : 2194 2198
6. Busch FM, Sayegh ES. Roentgenographic visualization of human testicular lymphatics: a preliminary report. J Urol 1963 89 : 106 110
7. Ray B, Hajdu SI, Whitmore WF Jr. Proceedings: distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 1974 33 : 340 348
8. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982 128 : 315 320
9. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987 138 : 77 82
10. Jewett MA, Kong YS, Goldberg SD et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 1988 139 : 1220 1224
11. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990 144 : 287 291
12. Heidenreich A, Albers P, Hartmann M et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 2003 169 : 1710 1714
13. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 89): modifications of technique and impact on ejaculation. J Urol 1993 149 : 237 243
14. Pizzocaro G, Salvioni R, Zanoni F. Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol 1985 134 : 485 489 (Pubitemid 16236379)
15. Richie JP. Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 1990 144 : 1160 1163
16. Weissbach LE, Boedefeld B, Horstmann-Dubral B. Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982-87. Testicular Tumor Study Group. Eur Urol 1990 17 : 97 106
17. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003 21 : 3310 3317
18. Heidenreich A, Thuer D, Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol 2008 53 : 260 272
19. Wahle GR, Foster RS, Bihrle R, Rowland RG, Bennett RM, Donohue JP. Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 1994 152 : 428 430
20. Pettus JA, Carver BS, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology 2009 73 : 328 331
21. Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 2007 110 : 1235 1240
22. Steiner H, Peschel R, Bartsch G. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary? BJU Int 2008 102 : 310 4
23. Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007 25 : 1033 1037
24. Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 2007 177 : 937 942
25. Carver BS, Shayegan B, Eggener S et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2007 25 : 4365 4369 (Pubitemid 350013841)
26. Sharp DS, Carver BS, Eggener SE et al. Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 2008 26 : 5524 5529
27. Efstathiou E, Logothetis CJ. Review of late complications of treatment and late relapse in testicular cancer. J Natl Compr Canc Netw 2006 4 : 1059 1070